The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Sabra Health Care REIT Inc

Nasdaq: SBRA
Last

(U.S.) $22.18

Today's change-0.59 -2.59%
Updated September 21 4:00 PM EDT. Delayed by at least 15 minutes.
 

Sabra Health Care REIT Inc

Nasdaq: SBRA
Last

(U.S.) $22.18

Today's change-0.59 -2.59%
Updated September 21 4:00 PM EDT. Delayed by at least 15 minutes.

Sabra Health Care REIT Inc crosses below 50-day moving average

Sabra Health Care REIT Inc closed sharply lower Thursday, dropping (U.S.)$0.59 or 2.59% to (U.S.)$22.18 and crossing below its 50-day moving average. Over the last five days, shares have lost 5.01% and are down 9.17% for the last year to date. This security has underperformed the S&P 500 by 20.12% during the last year.

Key company metrics

  • Open(U.S.) $22.77
  • Previous close(U.S.) $22.77
  • High(U.S.) $22.84
  • Low(U.S.) $22.18
  • Bid / Ask(U.S.) $22.16 / (U.S.) $23.36
  • YTD % change-9.17%
  • Volume1,438,296
  • Average volume (10-day)1,796,252
  • Average volume (1-month)2,759,094
  • Average volume (3-month)2,237,767
  • 52-week range(U.S.) $19.30 to (U.S.) $29.10
  • Beta0.89
  • Trailing P/E18.78×
  • P/E 1 year forward19.28×
  • Forward PEG7.71×
  • Indicated annual dividend(U.S.) $1.72
  • Dividend yield7.75%
  • Trailing EPS(U.S.) $1.18
Updated September 21 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.42%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue65636262
Total other revenue--------
Total revenue65636262
Gross profit60606061
Total cost of revenue4211
Total operating expense49464141
Selling / general / administrative12977
Research & development--------
Depreciation / amortization17191717
Interest expense (income), net operating16161616
Unusual expense (income)0000
Other operating expenses, total--------
Operating income16172121
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets40-31
Other--------
Income before tax21192325
Income after tax21192325
Income tax, total--------
Net income21192325
Total adjustments to net income-3-3-3-3
Net income before extra. items21192325
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items18162123
Inc. avail. to common incl. extra. items18162123
Diluted net income18162123
Dilution adjustment--------
Diluted weighted average shares66666666
Diluted EPS excluding extraordinary itemsvalue per share0.270.250.310.35
Dividends per sharevalue per share0.430.000.420.42
Diluted normalized EPSvalue per share0.210.250.360.33